Actively Recruiting
Austrian Left Atrial Appendage Closure Registry
Led by Medical University of Graz · Updated on 2024-11-21
200
Participants Needed
1
Research Sites
445 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
CONDITIONS
Official Title
Austrian Left Atrial Appendage Closure Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who received LAAC in Austria
You will not qualify if you...
- Absence of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Graz
Graz, Austria, 8036
Actively Recruiting
Research Team
D
Daniel Scherr, Assoc.Prof. PD Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here